Clinical Trial Update: Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing givinostat to hydroxyurea in patients with polycythemia vera is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Givinostat (givinostat)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Italfarmaco | Conditions: Polycythemia Vera | Phase 3 | Status: RECRUITING